» Articles » PMID: 11874946

Risk Indicators Predictive for Severe Hypoglycemia During the First Trimester of Type 1 Diabetic Pregnancy

Overview
Journal Diabetes Care
Specialty Endocrinology
Date 2002 Mar 5
PMID 11874946
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To investigate the frequency of severe hypoglycemia (SH) and hypoglycemic coma during the first trimester of type 1 diabetic pregnancy and in the 4 months before gestation and to identify risk indicators predicting first trimester SH in a nonselected nationwide cohort of pregnant women with type 1 diabetes.

Research Design And Methods: We conducted a longitudinal cohort survey in 278 pregnant type 1 diabetic women using questionnaires at inclusion and at 17 weeks of gestation, addressing the frequencies of SH (i.e., external help required) and hypoglycemic coma, general characteristics, hypoglycemia awareness, blood glucose symptom threshold, and the Hypoglycemia Fear Survey.

Results: The occurrence of SH (including hypoglycemic coma) rose from 0.9 +/- 2.4 episodes per 4 months before gestation to 2.6 +/- 6.3 episodes during the first trimester (P < 0.001), including an increase in episodes of coma from 0.3 +/- 1.3 to 0.7 +/- 3.7 (P=0.03). The proportion of women affected by SH rose from 25 to 41% (P < 0.001). First-trimester SH was independently related to a history of SH before gestation (odds ratio [95%CI]: 9.2 [3.9-21.7]), a 10 years' longer diabetes duration (1.6 [1.0-2.4]), an HbA1c level < or = 6.5% (2.5 [1.3-5.0]), and a 0.1 unit/kg higher daily insulin dose (5.4 [1.5-18.9]), adjusted for a decreased symptom threshold.

Conclusions: In type 1 diabetic pregnancy, the risk of SH is increased already before pregnancy and rises further during the first trimester. A history of SH before gestation, longer duration of diabetes, an HbA1c level < or = 6.5%, and a higher total daily insulin dose were risk indicators predictive for SH during the first trimester. Further research should aim to elucidate how the benefits of strict glycemic control balance with the markedly increased risk of SH early in pregnancy.

Citing Articles

Automated Insulin Delivery in Pregnancies Complicated by Type 1 Diabetes.

Benhalima K, Polsky S J Diabetes Sci Technol. 2025; :19322968251323614.

PMID: 40071788 PMC: 11904923. DOI: 10.1177/19322968251323614.


Pregnancy outcomes with the pregestational use of Minimed 780G compared to Minimed 640G: findings from a multicenter cohort study.

Perea V, Quiros C, Herrera-Arranz M, Azriel-Mira S, Wagner A, Beato-Vibora P Acta Diabetol. 2024; .

PMID: 39630235 DOI: 10.1007/s00592-024-02430-x.


Hypoglycemia Unawareness-A Review on Pathophysiology and Clinical Implications.

Holzen L, Schultes B, Meyhofer S, Meyhofer S Biomedicines. 2024; 12(2).

PMID: 38397994 PMC: 10887081. DOI: 10.3390/biomedicines12020391.


Automated Insulin Delivery for Pregnant Women With Type 1 Diabetes: Where Do We Stand?.

Benhalima K, Jendle J, Beunen K, Ringholm L J Diabetes Sci Technol. 2024; 18(6):1334-1345.

PMID: 38197363 PMC: 11535386. DOI: 10.1177/19322968231223934.


Risk Stratification in People with Diabetes for Fasting During Ramadan: Consensus from Arabic Association for the Study of Diabetes and Metabolism.

Shaltout I, Abdelwahab A, El Meligi A, Hammad H, Abdelghaffar S, Elbahry A Curr Diabetes Rev. 2023; 20(7):e201023222409.

PMID: 37867270 PMC: 11041120. DOI: 10.2174/0115733998249793231005105724.